Hong Kong · Delayed Price · Currency is HKD PegBio Statistics
Total Valuation
PegBio has a market cap or net worth of HKD 3.45 billion. The enterprise value is 2.97 billion.
| Market Cap | 3.45B |
| Enterprise Value | 2.97B |
Important Dates
The next estimated earnings date is Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PegBio has 391.09 million shares outstanding. The number of shares has increased by 3.19% in one year.
| Current Share Class | 284.30M |
| Shares Outstanding | 391.09M |
| Shares Change (YoY) | +3.19% |
| Shares Change (QoQ) | +4.32% |
| Owned by Insiders (%) | 12.28% |
| Owned by Institutions (%) | 22.26% |
| Float | 217.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.91 |
| P/TBV Ratio | 6.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.82 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -17.17 |
Financial Position
The company has a current ratio of 3.94, with a Debt / Equity ratio of 0.21.
| Current Ratio | 3.94 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.60 |
| Interest Coverage | -74.04 |
Financial Efficiency
Return on equity (ROE) is -82.42% and return on invested capital (ROIC) is -36.68%.
| Return on Equity (ROE) | -82.42% |
| Return on Assets (ROA) | -31.46% |
| Return on Invested Capital (ROIC) | -36.68% |
| Return on Capital Employed (ROCE) | -44.91% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.00M |
| Employee Count | 58 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 37.07 |
| 200-Day Moving Average | 50.73 |
| Relative Strength Index (RSI) | 24.12 |
| Average Volume (20 Days) | 12,216,604 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -228.98M |
| Pretax Income | -232.07M |
| Net Income | -231.87M |
| EBITDA | -228.00M |
| EBIT | -228.98M |
| Earnings Per Share (EPS) | -0.61 |
Balance Sheet
The company has 580.90 million in cash and 104.17 million in debt, with a net cash position of 476.74 million or 1.22 per share.
| Cash & Cash Equivalents | 580.90M |
| Total Debt | 104.17M |
| Net Cash | 476.74M |
| Net Cash Per Share | 1.22 |
| Equity (Book Value) | 499.20M |
| Book Value Per Share | 1.28 |
| Working Capital | 462.07M |
Cash Flow
In the last 12 months, operating cash flow was -169.04 million and capital expenditures -4.08 million, giving a free cash flow of -173.12 million.
| Operating Cash Flow | -169.04M |
| Capital Expenditures | -4.08M |
| Depreciation & Amortization | 1.01M |
| Net Borrowing | -19.91M |
| Free Cash Flow | -173.12M |
| FCF Per Share | -0.44 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PegBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.19% |
| Shareholder Yield | -3.19% |
| Earnings Yield | -6.72% |
| FCF Yield | -5.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |